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Objective. The correlation between obesity and deficient wound healing has long been established. This review examines the current
literature on the mechanisms involved in obesity-related perioperative morbidity. Methods. A literature search was performed using
Medline, PubMed, Cochrane Library, and Internet searches. Keywords used include obesity, wound healing, adipose healing, and
bariatric and surgical complications. Results. Substantial evidence exists demonstrating that obesity is associated with a number of
postoperative complications. Specifically in relation to wound healing, explanations include inherent anatomic features of adipose
tissue, vascular insufficiencies, cellular and composition modifications, oxidative stress, alterations in immune mediators, and
nutritional deficiencies. Most recently, advances made in the field of gene array have allowed researchers to determine a few plausible
alterations and deficiencies in obese individuals that contribute to their increased risk of morbidity and mortality, especially wound
complications. Conclusion. While the literature discusses how obesity may negatively affect health on various of medical fronts,
there is yet to be a comprehensive study detailing all the mechanisms involved in obesity-related morbidities in their entirety.
Improved knowledge and understanding of obesity-induced physiological, cellular, molecular, and chemical changes will facilitate
better assessments of surgical risks and outcomes and create efficient treatment protocols for improved patient care of the obese
patient population.

1. Introduction
Obesity is a growing and significant healthcare issue [1–4].
In 1910, Dr. Kelly described obesity, stating “to be a storehouse for useless adipose tissue and to carry this handicap
around, openly displayed wherever one goes, is one of the
most distressing of life’s minor ailments [5].” While current
viewpoints may be less extreme, obesity continues to carry
a social stigma and is increasingly present in our society
[2, 4, 6, 7]. According to recent figures, an average prevalence
of 35 percent of adult Americans is classified as obese and
5 percent morbidly obese, with this trend continuing [2, 8].
Obesity is responsible for more than 25 percent of the increase
in healthcare costs over the past 15 years [2, 4].
Body mass index (BMI) is one of the most objective methods in determining the presence and extent of obesity [9–11].
As BMI increases to obesity levels, morbidity and mortality

rates rise dramatically [4, 12–20]. The clinical definition for
obesity is a BMI ≥ 30 kg/m2 , with severe obesity defined
as a BMI ≥ 35 kg/m2 and morbid obesity as a BMI ≥
40 kg/m2 [2]. Patterns of obesity are affected by internal
as well as external and environmental factors, including
variables such as age, socioeconomic status, ethnicity, and
genetic background [2, 3].
Surgical attempts have been made to correct obesity, such
as bariatric surgery and direct surgical excision. Bariatric
surgery refers to any of the various surgical procedures
performed to treat obesity by modification of the gastrointestinal tract to reduce nutrient intake and/or absorption
[12, 14, 21–25]. Direct surgical excision, individualized to each
patient’s needs, may include circumferential abdominoplasty,
panniculectomy, brachioplasty, thighplasty, and/or liposuction [7, 26–28]. Usually performed after massive weight
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loss following bariatric procedures, surgical excision is an
important aspect of treatment for many patients as they often
view the redundant tissues as the last barrier to resuming
“normalcy”, both for cosmetic reasons as well as for physical
comfort [29].
From a surgical standpoint, obesity is associated with a
multitude of complications including impairments of cutaneous wound healing, total wound failure, and fascial dehiscence [10, 30–39]. Complications can be observed following
various surgeries including gastric bypass and panniculectomy [29, 32, 40–42]. While health benefits of bariatric
surgery are well recognized, serious complications can result
in 2–4% of patients [43]. A 2006 study of postbariatric
patients found that over the ensuing six months after surgery,
complication rates actually approached 40 percent [2]. These
complications included abdominal pain, nutritional deficiencies, endocrine or metabolic disorders, gastrointestinal
disorders, and wound compromise. Additionally, patients
who have had prior bariatric surgery and subsequently
undergo additional surgical procedures may have similar
complications as their BMI may persist to be within the obese
category [36]. As these postsurgical complications often
result in unplanned hospital and emergency room visits, as
well as readmissions, there is an imperative need to improve
the outcomes of surgery performed on obese patients in order
to help decrease health care costs, healing time, and time away
from work [2].
Many studies have observed an association between
obesity and a myriad of complications [10, 30–39]. Few,
however, specifically address the exact mechanisms involved
in the deficiencies observed in obese patient wound healing,
compared to patients of normal weight. The determination of
these mechanisms may allow researchers to pursue a solution,
or at least an improvement, to decrease complications and
facilitate improved surgical outcomes in the obese patient
population.

2. Methods
A literature search was performed using PubMed, Medline,
the Cochrane Library, and Internet searches. Keywords
used included obesity, wound healing, adipose healing, and
bariatric and surgical complications. In addition, a manual
search for other articles pertinent to the study was performed.
A discussion focusing on the effects of obesity on wound healing, specifically in relation to postoperative complications,
is presented. Potential etiologic factors involved and current
plausible mechanisms are explained.

3. Discussion
3.1. Complications. Obesity is associated with comorbidities
and poor outcomes in a number of medical areas [10, 30–
39]. Studies show that even a 10-kilogram weight loss in
obese patients can decrease diabetes-related morbidity and
mortality by 30% [4, 7, 24]. Improvements are significant
in disease processes involving endocrine (diabetes), cardiovascular (hypertension, hyperlipidemia, and coronary artery
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disease), rheumatic, and hypercoagulation disorders (deep
vein thrombosis and pulmonary embolism) [2, 3, 17, 24, 44–
46]. Reductions in the severity of symptoms relating to sleep
apnea and depression have also been observed [2, 3, 47]. It
is important to note that even with the substantial weight
loss seen after bariatric procedures, many patients are still
considered obese based on their BMI [41, 48].
A higher BMI has repeatedly been correlated with
increased mortality resulting from cancers of the uterus,
breast, ovary, prostate, colon, and rectum [47, 49]. Baseline
values of BMI are an independent predictor of cardiovascular
mortality alone [50]. The association of BMI with mortality
is further supported by its consistency across different sexes
and ethnic groups, with the strength of effect being the main
variation [51]. Obese patients suffering a traumatic injury are
also at an increased risk of developing multiorgan failure [44].
Since other studies have noted visceral adiposity as having a
stronger correlation with increased morbidity and mortality,
both BMI and visceral adiposity should be considered as
factors that affect the health status of a patient at the time of
surgery and during recovery [52–54]. Furthermore, a higher
BMI is correlated with increased infection rates in trauma
patients [55]. Compared with nonobese surgical patients,
obese patients have an increased incidence of surgical complications, including atelectasis, thrombophlebitis, mortality,
wound infection, and wound separation [3, 10, 19, 30–32, 34–
39, 47, 48, 56–62]. Clearly, there is strong evidence indicating the association between obesity and poorer surgical
outcomes, especially in relation to wound healing. However,
the mechanisms responsible for these outcomes are not well
known nor understood.
Several studies postulate the mechanisms by which obesity increases wound complications. Potential factors include
the intrinsic tenuous anatomic properties and poor vascularity of adipose tissue [63–65]. Relative vascular insufficiency,
thus decreased oxygen tension, may result in decreased
collagen synthesis, decreased capacity to fight infection, and
decreased ability to support the necessary mechanisms of the
healing cascade [66–73].
3.2. Anatomy. Adipose tissue is a distinct entity often perceived as relatively avascular [6, 74, 75]. From this standpoint,
ischemic associations are made and used in an attempt to
rationalize responses of adipose tissue to various stressors.
A study contradicting this theory of avascularity notes the
anatomy of adipose tissue is subdivided into lobules, each
made up of thousands of cells which are separated by fibroush
septa carring relatively large vessels and neurons [64]. The
blood supply to each lobule comes through a vascular pedicle,
with fine-meshed capillary retia encompassing every fat cell.
The percentage of capillary beds to active cytoplasm in fat
cells is in fact similar to that of skeletal muscle, a wellvascularized tissue [5, 64]. As excess adiposity causes an
increased demand on the circulation, adipose tissue begins
to develop its own vascular system. Vascular insufficiencies
arise in obesity because the capillary density does not increase
proportionally to the increase in adipose tissue [76]. This
may be due to several factors, one of which is a decrease
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in elastin and an increase in collagen V and VI around the
large vessels of adipose tissues, resulting in a profibrotic environment [77, 78]. These changes in the extracellular matrix
contribute to fibrosis and increased adipose tissue rigidity,
likely hindering the expansion of individual adipocytes. This
can also potentially restrict capillary proliferation, leading
to impaired angiogenesis. Compounding to this fact is the
greater number of large blood vessels in obese individuals.
Larger vessels have a greater diffusion barrier so they do
not deliver oxygen as efficiently as capillaries. Altogether,
decreasing capillary density and increasing number of larger
vessels lead to decreased perfusion of adipose tissue and
predispose it to a hypoxic environment. This could be a
significant detractor for vascular regeneration and oxygen
perfusion needed in wound healing. While the strain on
circulation created by surplus adipose mass already exists,
capillary damage from injury further exacerbates this hypoxic
environment.
Structurally, the delicate nature of fat lobules makes it
more susceptible to mechanical damage—the in-situ resistance ascribed to only the supporting structures [64]. These
supportive structures, however, do not develop correspondingly to increasing fat volume [64]. Surgical intervention can
render these supportive structures inactive and readily cause
adipose weakness. Additionally, fat lobules are units with
terminal circulation and severance of the lobule may destroy
blood supply, leading to necrosis of the whole unit [64, 65,
73]. Capillary proliferation occurs maximally at the wound
surface during normal wound healing. However, necrosed
or damaged adipose lobules can complicate this process
[31, 64, 79]. With full-thickness skin grafts, complications
arise when residual adipose tissue is attached to the graft
[64, 65, 80]. Adipose tissue appears to inhibit the flow of
wound serum into grafted skin, a process essential to the
graft’s survival. It is postulated that this interaction is due
to the adipocytes’ absorption of wound serum with failure
to subsequently transfer it to the graft, a theory supported
by the substantial edema noted in grafts containing residual
adipose tissue, and decreased revascularization of these grafts
since fewer capillary links with the dermis exist among
the vascular anastomoses between the wound base and the
lobules [64, 80]. Decreased angiogenic capacity of adipose
tissue in conjunction with decreased oxygenation of graft
tissue can lead to hypoxia.
Adipose tissue grafting is notable for variable and often
unsatisfactory results due to loss of volume. Fat lobules
damaged or severed on removal of the graft are likely to be lost
[64]. Rapid revascularization would involve using original
vessels, but due to the anatomical features of adipose tissue,
this can only occur indirectly. Indirect revascularization
possibly results in substantial delay and thus, increased
loss of cells incapable of tolerating the ischemic stress as
hypoxia may be a risk factor for increased adipocyte death
in obese patients [64, 65, 73, 81]. Once becoming necrotic,
fat grafts cannot be resorbed but rather need macrophage
uptake for elimination [64, 65]. Macrophage recognition of
necrotic adipose as a “foreign body” may lead to initiation
or perpetuation and extension of the inflammatory phase of
an acute or chronic wound. This reaction can be detrimental
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to ideal healing processes as “foreign bodies” delay the
progression of wounds to the fibroproliferative phase, a
critical wound healing period where tensile breaking strength
quickly increases [61, 82]. Fat necrosis and subsequent foreign
body reaction can be substantial if surgical manipulation is
not performed along anatomical limits of the fat layer [64].
3.3. Vascularity. Several studies describe the “inherent”
decreased vascularity of adipose tissue as leading to its
associated wound complications [6, 74, 75]. Increased adiposity sets off a cascade that positively feeds back into
impaired angiogenesis and chronic low-grade inflammation.
In addition to the overexpression of collagen VI (col6),
obesity is associated with increased expression of 11f3hydroxysteroid dehydrogenase type 1 (11f3HSD1), an intracellular glucocorticoid-amplifying enzyme [83]. Glucocorticoids suppress angiogenesis so the elevated level of 11f3HSD1
amplifies the inhibitory effects of glucocorticoids [84, 85]. As
adipose tissue becomes hypoxic from impaired angiogenesis,
hypoxia-inducible factor 1 alpha (HIF1𝛼) levels increase
[86]. Elevated HIF1𝛼 levels initiate local inflammation and
fibrosis by activating the collagen I and III cross-linking
activity of lysyl oxidase (LOX). Consequently, overexpression
of these factors impairs wound healing by suppressing the
angiogenic process needed to restore the wound vasculature
and contributes to the obesity pathogenesis of hypoxia and
fibrosis. Other proposed mechanisms in which excessive adiposity leads to microvascular abnormalities include reduced
nitrogen oxide (NO) availability impairing development of
microvascular rarefaction and prolonged elevation of free
fatty acids in the blood from increased fat mass impairing
capillary recruitment [76, 87, 88].
Yet, a few studies debate this viewpoint of inherent
decreased vascularity, pointing to the finding that undisturbed adipose is well perfused [58, 64, 65]. Only in particular
scenarios is decreased vascularity observed, such as surgical
and other traumatic injuries that result in adipose lobule
disruption and consequent relative avascularity [64]. In
response to ischemic stimulation, obesity in murine models
suppresses the ability of adipose-derived endothelial progenitor cells (EPC) to differentiate, reducing the circulating level
of EPCs available to function in blood vessel endothelial
repair and angiogenesis [89]. Regardless of whether the
avascularity is inherent or acquired, the compromise of blood
flow and subsequent poor oxygenation can lead to disruption
of the normal healing process and/or eventual necrosis of the
tissue [64, 90, 91].
Venous insufficiency is another vascular factor associated with the development of chronic wounds and delayed
wound healing. The association between obesity and venous
insufficiency is well established, but the exact mechanisms
for wound disturbances are only beginning to be realized.
Understanding of the more advanced clinical stages of venous
disease in obese patients has led to a proposal in which
raised intra-abdominal pressure may cause the greater reflux,
increased vein diameter, increased venous pressure, and ultimately, impaired venous function [92]. Venous insufficiency
impairs wound healing by forming a barrier surrounding
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capillaries and decreasing effective diffusion of oxygen and
nutrients from capillaries to surrounding tissue [66–68, 71,
73]. Once venous insufficiency is present, proteinaceous
material may accumulate in the interstitium surrounding
the capillaries, leading to clotting and eventual fibrosis of
these vessels [93, 94]. Additionally, components of intravascular fluid may leak into the surrounding tissues because
of increased hydrostatic pressure, inciting an inflammatory
response [95]. These factors create a “barrier” through
which oxygen and nutrients cannot transverse to supply
surrounding tissue. Furthermore, leukocytes may become
trapped and accumulate, contributing to poor oxygenation
and tissue destruction by releasing lysosomal enzymes and
proinflammatory mediators [93, 94]. These mechanisms create a feasible argument for the role of venous insufficiency in
contributing to impaired wound healing.
3.4. Cellular and Molecular Alterations. Advances in the field
of gene array offer a potential to investigate the changes
corresponding with obesity [96]. The discoveries of obesityinduced changes in adipose tissue emphasize that obesity may
initiate and perpetuate a chronic low-grade inflammatory
process. A study of obese mice demonstrated a progressive
increase in proinflammatory cytokine production resulting
from the activation of invariant natural killer T (iNKT) cells
by the excess lipid. This occurred before or at the time of
inflammatory leukocyte recruitment [97]. Furthermore, the
iNKT cells influenced other leukocytes to produce proinflammatory cytokines, resulting in an imbalanced proinflammatory cytokine milieu. Other inflammatory mediators that increase concomitantly with adipose tissue mass
include angiotensinogen, tumor necrosis factor alpha (TNF𝛼), leptin, interleukin 6 (IL-6), and transforming growth
factor beta (TGF-𝛽). [1] Additionally, pathologic inflammatory changes related to increased macrophages, mononuclear
and polymorphonuclear cells, and inflammatory cytokines
have been shown in obesity studies to be dependent upon
the degree and duration of obesity [1, 96, 98, 99]. [1] As
lipopolysaccharide levels increase, the scavenger receptor
CD36 enhances adipose tissue inflammation and cell death
through its expression on and synergistic modulation of
both macrophages and adipocytes [100]. Specifically, the
activation state of adipose tissue macrophages shifts from the
protective and anti-inflammatory M2-polarized state to an
M1 proinflammatory state as a result of diet-induced obesity
[101]. M2 macrophages aid in tissue repair and homeostasis
and produce anti-inflammatory cytokines [102]. In obese
mice, chronic inflammation caused by mediators such as
TNF-𝛼 can cause skin gamma delta T cells to be unresponsive
to damage in the epithelium, preventing the release of
cytokines and growth factors that facilitate wound repair
and making the wound vulnerable to injury and infection
[103]. Thus, the shift in macrophage activation and other
immune mediators towards a proinflammatory state likely
impairs wound healing in obese patients by compromising
immunoregulation and altering the inflammatory stage of
wound repair. The view that obesity induces a chronic lowgrade inflammatory process is supported by findings of
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a reduction in macrophage infiltration and chemoattractant
gene expression following weight loss [1, 96].
3.5. Oxidative Stress. Obesity, especially abdominal obesity, is
positively correlated with oxidative stress [104]. This is partly
attributed to a deficiency in adiponectin, an adipose-derived
cytokine that protects against oxidative stress and inflammation [105, 106]. Paradoxically, adiponectin concentration
decreases with obesity although it is secreted by adipocytes
[107]. A deficiency of adiponectin impairs wound healing
via two mechanisms. In response to ischemic stimulation,
adiponectin stimulates angiogenesis by promoting AMPactivated protein kinase signaling. Secondly, adiponectin
activates the ERK signaling pathway to promote keratinocyte
proliferation and migration, a critical process in the reepithelialization phase of wound healing [108]. Therefore, decreased
adiponectin impairs proper perfusion and reepithelialization
of the wound.
Decreased oxygen tension is present in “normal”
wounded tissue and is a major factor in the susceptibility of
wounds to infection [66, 67, 69, 109, 110]. Baseline oxygen
tension was noted to be the lowest in infected wounds,
with the most critical range being between 0 and 40 mmHg
[71, 73]. The hypovolemia and impaired tissue perfusion
of the wound may exacerbate the preexisting relative
hypoperfusion of adipose tissue that resulted from the
expansion of fat mass without a synchronized increase
in blood flow per cell [111]. This can cause a critical
reduction in oxygen delivery to adipose tissue, as seen in the
impaired tissue perfusion of the morbidly obese during the
perioperative period [88].
The hypoperfusion of subcutaneous adipose tissue in
obese patients may predispose them to a greater risk of
acquiring a surgical site infection [110]. This is likely from a
greater risk of ischemia and necrosis and deficiencies in the
oxidase system of leukocytes [69, 112, 113]. In the normal,
unhindered process, phagocytosis is followed by a burst of
oxygen consumption, which coincides with bacterial death
[68, 69, 71, 112]. This oxygen consumption is essential to
the bactericidal mechanisms of the host’s defense system.
In an oxygen deficient setting, leukocytes can ingest the
bacteria but are unable to kill them [71]. Bacteria cultured
from infected wounds of obese patients have been noted to
be similar to longstanding wounds of chronic granulomatous
disease patients, where the main issue is a defective oxidase
system (i.e., Staphylococcus, E. coli, Klebsiella, and Candida)
[68, 70, 71, 112, 114]. The positive feedback interaction between
the altered immune responses and local inflammation in
adipose tissue contributes to the development of metabolic
complications and impaired wound healing in the obese [115].
Infection significantly affects wound healing and preparation of the wound bed. Optimal healing requires eradication
of infection [82, 116–119]. Therapies with proven efficacy
incorporate minimizing necrosis, bacterial load, and inflammation of the wound bed, all the while maintaining regenerative tissue cells to aid in wound healing [120]. A fine balance
exists between the host’s defense system and the pathologic
effects of bacteria [82, 119, 121]. The faster and more effectively
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the immune system combats infection, the less disturbed the
normal wound healing process and the better the outcome for
the patient. Deficiencies in oxygen utilization and increased
inflammation associated with adipose tissue partially explain
the mechanisms of increased wound infections prominent in
obese patients.
Another aspect of wound healing that is potentially
affected by hypoxia is fibroblasts’ capability to synthesize
collagen [73, 93, 94]. Although fibroblasts are able to survive
in a hypoxic environment, they cannot proliferate or synthesize collagen properly [73]. Biochemically, the complete
absence of oxygen inhibits the hydroxylation of proline
and lysine, preventing the final assembly of the collagen
molecule [122]. Clinical support of this is evident in the
finding of collagen deposition and synthesis being directly
proportional to oxygen tension in postsurgical patients [67,
68]. As a result, injured tissues, especially damaged adipose
lobules that already have an insufficient vascular supply and
experience further oxygen perfusion deficits after an injury,
have decreased resources to meet metabolic needs and have
a limited ability to effectively produce collagen. Without
sufficient collagen IV and V to promote the aggregation of
platelets in the subendothelium, hemostasis is delayed and/or
impaired [123]. This likely translates into poor wound healing.
Collagen synthesis is an essential part of the wound healing process and subsequent integrity of the wound [124–127].
It is a key element in establishing maximum tensile strength
[67, 124–127]. The upregulation of collagen I and III expression has been shown to accelerate cutaneous wound healing
in rats [128]. This process is impaired in obesity because
excessive adiposity increases the expression of immature type
III collagen and disorganized type I collagen fibers [129].
Without the appropriate collagen, the collagen matrix cannot
remodel properly, which reduces the mechanical strength
and yield required for the recovery of wound strength and
healing.
3.6. Micronutrient and Macronutrient Deficiencies. Wound
healing involves the well-coordinated processes of hemostasis, inflammation, granulation tissue formation, fibrogenesis,
neovascularization, contraction, and reepithelialization [130].
In order for the cellular responses and homeostatic mechanisms to occur properly, there must be sufficient vitamins,
minerals, and proteins present, that is, there must be sufficient nutrients available. This requirement necessarily places
obese patients at a disadvantage because they suffer from a
paradoxical malnutrition resulting from a calorie-dense diet
that is high in carbohydrates and fats and low in vitamins
and minerals [131]. Eventually, nutritional deficiencies occur.
Blood tests and biochemical analysis on bariatric surgery
candidates preoperatively revealed an astonishingly high
occurrence of micronutrient and macronutrient deficiencies,
particularly vitamin B12, 25-OH vitamin D3, zinc, albumin,
and iron, with the latter two increasing significantly with BMI
[132–136]. Other nutritional deficiencies amongst bariatric
surgery candidates include folic acid, ferritin, phosphorus,
calcium, magnesium, vitamin A, vitamin B6, vitamin C, and
copper [133–135, 137, 138].
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Almost immediately after the occurrence of a wound,
hemostasis begins to take place. Calcium, predominantly
involved as factor IV, is critical in this process as it is
required for the activation of many intercellular reactions,
serving as a primary catalyst in platelet aggregation and in
the production of clotting Factors VIII, IX, and X [123, 139].
Calcium is recruited again later on for the activation of
neutrophils, migration of cells, regeneration of epidermal
cells, and modulation of keratinocyte proliferation and differentiation. Without sufficient vitamin D, however, calcium
cannot be absorbed in the small intestines [140]. Vitamin D
deficiency is also associated with obesity [141, 142]. BMI may
be a risk factor for vitamin D deficiency, with deficiencies
even evident in obese children [143]. Vitamin D has a
range of physiological functions, from regulating B cells and
bone metabolism to maintaining calcium homeostasis [141,
144]. The role of vitamin D in adipose tissue signaling is
being unraveled, with recent findings of vitamin D reducing
lipid accumulation in adipocytes and exhibiting an antiinflammatory effect in adipose tissue [144]. This implies that
vitamin D has an immunomodulatory function in adipose
tissue and deficiencies may lead to adipocyte dysfunction and
impair wound healing.
Proper wound healing also requires the minerals zinc
and copper. DNA and RNA polymerases require zinc in the
repair processes as it helps the metabolism catalyze more than
200 enzymes, facilitates protein folding, and regulates gene
expression [123, 145]. Adipose tissue metabolism requires
zinc to regulate the secretion of leptin, an adipocytokine, and
promote free fatty acid release and glucose uptake [146]. Obesity is associated with leptin resistance; thus, the abnormal
metabolism resulting from zinc deficiency may contribute
to impaired wound repair [106]. During the inflammatory
and fibrogenesis processes, zinc and zinc metalloenzymes
assist in immune and inflammatory responses, collagenesis,
matrix degradation, epidermal regeneration, and scar formation [123, 146, 147]. Low zinc intake is associated with
low superoxide dismutase activity in obese individuals, likely
accounting for why zinc deficiency increases oxidative stress
and the inflammatory response [148]. In a clinical study, oral
administration of nutritional doses (15 mg elemental zinc)
of zinc to burn patients significantly improved outcomes
by elevating the level of glutathione (a natural antioxidant),
decreasing the incidence of eschar formation, improving the
antioxidant status, increasing healing time, and decreasing
the mortality rate [149]. In addition, copper is needed by lysyl
oxidase in collagenesis and elastic tissue formation and may
also have a role in stabilizing epidermal cells [123].
The inflammatory stage may be prolonged if vitamin A
is deficient as low vitamin A serum levels correlate with
increased oxidative stress and Th1 response, which potentially
can heighten the inflammatory processes already involved
in the chronic inflammation and fat deposition inherent in
obesity [148]. Vitamin A is needed again in collagenesis and
epithelialization to increase the rate of collagen synthesis,
cross link new collagen, promote epithelialization, and close
wounds [23, 150, 151]. Experimental animal studies have
shown that vitamin A accelerates the healing of incisions
by hastening the formation of granulation tissue [150, 152].
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Vitamin A also has the capability of decreasing the severity
of bacterial and fungal infections [151]. Due to the increased
nutritional requirements for wound healing, it is recommended to give five times the normal supplemental vitamin.
A requirement to all patients after an injury, regardless of
the patient’s nutritional status [150, 151]. Vitamin A can also
reverse the negative effects of steroids on wound healing
so it may contribute to improved wound healing in various
compromised states, for instance, obesity [153–155].
Throughout the process of wound healing, there are also
other nutritional factors that are required, such as vitamin B.
B complex vitamin deficiencies are concerning as they influence wound healing and other processes [94, 156–160]. B12
injections have been shown to increase the tensile strength
of wounds and facilitate superior wound healing [82, 158].
Components of vitamin B complex also serve as cofactors for
a number of enzyme systems. Dysfunction of these enzyme
systems can affect protein, carbohydrate, and fat metabolism,
as well as disturb antibody and white cell functions [70,
157, 158, 160]. Severe deficiencies impair the synthesis of
DNA, proteins, and other crucial molecules, leading to
megaloblastosis as well as hindering cellular proliferation and
repair [161]. Furthermore, megaloblastosis can result in the
development of megaloblastic anemia, which may adversely
affect circulation. To maintain sufficient vitamin B intake for
patients who are severely injured or acutely ill, five to ten
times the normal amount of B complex vitamins is usually
recommended [64].
Iron is also crucial for proper wound healing. Iron
deficiency in the obese may be due to a decrease in dietary
iron intake, the effects of obesity-related inflammation on
dietary iron absorption, and/or the sequestration of iron as
a result of chronic inflammation [148, 162]. Both BMI and
inflammation have been shown to predict iron absorption
and affect iron fortification response [163]. It is plausible
that hepcidin, an inhibitor of intestinal iron absorption
and activator of iron sequestration by macrophages, is a
mediator as it is directly correlated with the degree of obesity
and indirectly correlated with iron absorption [148, 164,
165]. Iron is also required in the hydroxylation of lysine
and proline; therefore, insufficiencies of this element can
lead to decreased tensile strength in wounds [166, 167].
Additionally, decreased iron absorption may result in iron
deficiency anemia. This can diminish oxygen transport and
potentiate secondary effects on wound healing due to relative
hypoxia in healing tissues [150, 167, 168]. Iron deficiency also
results in a dampened leukocyte bactericidal ability, further
complicating healing by weakening the wound’s defense
system [169].
Protein malnutrition also significantly affects wound
healing because it is needed for fibroblast proliferation, angiogenesis, and collagen production [150, 161]. An albumin level
lower than 2 is associated with a number of wound healing
impairments including a prolonged inflammatory phase,
decreased fibroplasia, which leads to delayed wound healing, and decreased neovascularization [150]. Additionally,
decreased cell synthesis and wound remodeling, diminished
wound strength, impaired T-cell function, and phagocyte
activity, as well as decreased complement and antibody levels,
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all contribute to the delayed healing observed in protein
deficient states [170–173].
Carbohydrates and fat intake also affect wound metabolism [150, 174]. Together, carbohydrates and fats are the major
source of energy in the body and consequently in the wound
healing process. The metabolic syndrome commonly associated with obesity may lead to insulin resistance, rendering the
body less adept at maximally utilizing glucose, a breakdown
product of carbohydrates [175]. Indirectly, insufficient carbohydrates and/or fats will force the body to look for alternate
forms of energy, leading to excess oxidation of amino acids
to satisfy caloric needs [150]. Following injury, obese patients
preferentially oxidize proteins and carbohydrates, possibly
from a block in the utilization of free fatty acids [176]. Amino
acid use further perpetuates protein malnutrition and their
effects on wound healing. Directly, the energy requirement
of leukocytes and fibroblasts is increased after injury, and
if unfulfilled, can result in impaired wound healing [150].
This altered metabolic function after trauma and injury can
reduce the immune response. Cumulatively, all these factors
contribute to increasing wound complications and wound
failure rates.
3.7. Special Considerations. Gastric bypass (GBP) surgery can
be utilized to correct obesity by helping patients achieve
and maintain weight loss [2, 36, 47]. An important topic
often left unaddressed with patients, however, is the increased
risk of possible wound complications following surgery. The
nature of GBP surgery leaves patients in a state of “deliberate
malnutrition,” possibly exacerbating the altered metabolic
response and nutritional deficiencies already present in the
obese patient. GBP patients, in addition to the normal
challenge of maintaining the 25% increase in required protein
and caloric intake for wound healing postoperatively, are
faced with a new and less effective gastrointestinal anatomy
for maintaining the nutrients needed postoperatively [150].
Many post-GBP patients have protein-calorie malnutrition
in addition to various vitamin and mineral deficiencies. [177]
Post-GBP nutritional deficits in iron, vitamin B12, folate, vitamin A, thiamine, calcium, potassium, and magnesium are relatively common [178, 179]. Following major elective surgery,
additional nutritional deficits include reductions in nitrogen,
potassium, sulfur, and phosphorus [150]. These deficits are
compounded by postsurgical requirements for increased
ascorbic acid, thiamin, riboflavin, nicotinamide, and vitamin
A, compared to normal daily needs. This further reduction
in the quantity of nutrients available for use can lead to an
increased risk of medical complications [20, 174]. In a study
of postbariatric patients, all of them experienced wound
complications following abdominoplasty because they had a
reduction of nearly 60% for total tissue protein [177]. These
same patients had a reduction of 72% in the amino acid
hydroxyproline, a major constituent of collagen, leading to
a decrease in tensile strength of the wound. However, a
reduction in surgical complications is achievable by giving
nutritional supplements to obese patients prior to surgery.
Dietary recommendations suggest that unsaturated fatty
acids comprise 4–8% of daily caloric intake in injured patients
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who experience metabolic/physiologic derangements that
are prolonged (as in post-GBP patients) [150]. This amount
is roughly double the amount recommended for healthy
patients [94, 158, 159]. Diet adjustments of post-GBP patients
that subsequently undergo panniculectomy or other surgical
procedures must be quantified and supplemented in order
to maintain sufficient nutritional status. The inability to
provide for these requirements can significantly affect patient
outcome. Vitamin and protein deficits diminish phagocytic
and lymphocytic activity, directly impairing the immune
system, after only 4 weeks in this nutritional setting [82,
116, 118]. While nutrition teams closely follow patients postoperatively and advances in supplementation attempt to
correct nutritional deficiencies after surgery, the system is by
no means perfect as patient noncompliance can negatively
impact nutritional and metabolic complications [2, 20, 47,
174].

4. Conclusion
Obesity is a pervasive health issue in today’s society. It
induces complex negative effects on multiple organ system
functions and processes, including issues related to wound
healing. Efforts to decipher the origins, physiology, and
health consequences of obesity on the human body are an
imperative focus in current investigations. Numerous studies
have shown the correlation between obesity and abnormal
wound healing, with knowledge of the exact mechanisms in
the infantile stages. Theories on credible contributing factors
are presented in this review.
Healthy adipose tissue is beneficial to the human body as
it serves as an insulator and paracrine and endocrine organ,
secreting cytokines, growth factors, and immune mediators.
Uninjured adipose tissue has a comparable vascular supply to
other uninjured tissue types, but its tenuous anatomic configuration leaves it weaker and more susceptible to mechanical
damage. Since each lobule is supplied by terminal blood
vessels, damage to the area may result in necrosis of the entire
lobule.
Problems arise as excessive adiposity modifies the cellular composition and structure of adipose tissue, as well
as changing the physiology of the skin and subcutaneous
tissues. Obesity induces adipocyte hypertrophy and hyperplasia, eventually impairing the metabolic functions of the
adipocytes, such as storing fat. It may be that the metabolic
dysfunction is the primary activator in the cascade of obesityinduced problems. Following metabolic dysfunction, inflammatory mediators begin to invade the adipose tissue, leading
to a chronic, low-grade inflammatory process that is well
associated with obesity. The phenotypic switching of protective M2 macrophages to proinflammatory M1 macrophages
exacerbates this problem. As adipocytes grow in size and
number, blood vessels develop into the new areas of adipose tissue growth. However, the rate of angiogenesis does
not parallel the rate of adipocyte growth. Compounding
these properties, obese adipose tissues secrete angiogenic
inhibitors and fibrotic mediators. The extracellular matrix
remodeling may further impede the process of angiogenesis
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by creating a stiffer environment and preventing the migration of cells and vessels. Without sufficient supply of blood
vessels to oxygenate the area, relative hypoxia ensues. The
hypoxia caused by damage to capillaries in wounds and
the relative hypoxia in obese individuals likely contribute to
higher rates of wound infections in obese patients because
of even lower oxygen tension from decreased perfusion and
impaired immune system functioning. Additionally, hypoxic
wounds impair the synthesis of mature collagen, leading to
weaker tissue and deficiencies in the overall healing process.
Thus, the microvascular abnormalities as a result of excessive
adiposity contribute to obesity-related microangiopathy.
The vascular insufficiencies and altered population of
immune mediators present may lengthen the inflammatory
stage of wound healing, as well as leaving obese individuals
more susceptible to infections. Wound healing is also delayed
as a result of macronutrient and micronutrient deficiencies
in obese individuals. Without the proper cofactors and
enzymes, the process of wound healing is compromised, as
well as the integrity of the wound. Nutritional supplements
can be given to obese patients preoperatively as a possible
solution to decrease wound complications. For bariatric
surgery candidates, special considerations need to be made as
they are at increased risk of nutrition-related complications.
Although the detrimental effect of obesity on wound
healing is established, there is a need for additional studies
to determine the comprehensive mechanisms involved in
this relationship. Some of the key alterations and deficiencies
in obese adipose tissue that already have been determined
are presently undergoing investigations that utilize targetspecific therapies. Perhaps the breakthrough with obesity
and wound healing will be in the realm of growth factors,
cytokines, nutritional manipulations, surgical techniques, or
in gene array studies. Most likely, interventions will involve a
combination of these factors and others. With the prevalence
of obesity in today’s society and its evidenced effects on health
care, the challenge of altering adipose tissue’s effect on wound
healing remains one which necessitates further exploration.
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